Patient-reported outcomes and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study

被引：0

作者：

Murrell, Dedee F. ^{[1
]}

Ferrucci, Silvia M. ^{[2
]}

Foti, Caterina ^{[3
]}

Perez-Garcia, Bibiana ^{[4
]}

Lapeere, Hilde ^{[5
]}

Calzavara-Pinton, Piergiacomo ^{[6
]}

Fougerousse, Anne-Claire ^{[7
,8
]}

Wu, Jiangming ^{[9
]}

Ardeleanu, Marius ^{[10
]}

Bosman, Kwinten ^{[11
]}

机构：

[1] Univ New South Wales, St George Hosp, Sydney, NSW, Australia

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[3] Univ Bari Aldo Moro, Bari, Italy

[4] Ramon & Cajal Univ Hosp, Madrid, Spain

[5] Ghent Univ Hosp, Ghent, Belgium

[6] Univ Brescia, Brescia, Italy

[7] Mil Teaching Hosp Begin, St Mande, France

[8] ResoEczema, Paris, France

[9] Sanofi, Bridgewater, NJ USA

[10] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[11] Sanofi, Amsterdam, Netherlands

来源：

关键词：

real-world evidence; dupilumab; atopic dermatitis; patient-reported outcomes;

D O I：

10.1093/bjd/ljae266.016

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

634

引用

页数：2